Dr Pamela Lee (李珮華)
MBBS (HK), MD (HK), FHKCPaed, FHKAM (Paediatrics)
Assistant Dean (Clinical Curriculum) Programme Director (Pedagogy and Training), Bau Institute of Medical and Health Sciences Education Clinical Associate Professor Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong
Paediatric Immunology and Haematopoietic Stem Cell Transplantation
Department of Paediatrics & Adolescent Medicine
Room 119, 1/F, New Clinical Building
102 Pokfulam Road, Queen Mary Hospital, Hong Kong
HKU Scholars Hub
Total citations: 2,137 (Google Scholar)
Field of Research
Teaching & Learning
Research Postgraduate Supervision
LEE Wing Yan (M.Phil., 2007). Association of cytokine gene polymorphisms with susceptibility and disease progression in chronic hepatitis B virus infection
PEI Lim Cho Steven (PhD, 2016). Possible role(s) of interferon regulation on inflammasome activity via STAT1 and autophagy.
KUI Lin (PhD, 2018). The effect of tumor necrosis factor-inducible gene 6 (TSG-6) and hTERT mesenchymal stem cells (htMSC) derived extracellular vesicles on TRL9 and TLR7 stimulated plasmacytoid dendritic cells and their therapeutic potential in systemic lupus erythematosus.
MA Haiyan (PhD, 2019). NLRP3 inflammasome contributes to host defense against Talaromyces marneffei infection.
Improving Care, Education and Research: The Asian Primary Immunodeficiency Network
The Asian Primary Immunodeficiency (APID) Network is a collaborative research network committed to advancing basic science and clinical practice of primary immunodeficiencies (PID). Based in UPAM, the APID Network provided genetic confirmation of PID for nearly 900 patients in Asia, thereby increasing the visibility of these rare disorders and calls for attention to service needs and priorities. Characterization of disease patterns, unique phenotypes, genetic etiologies and disease mechanisms that are not previously described in Asia enable clinicians to recognize PID in their locality and accelerate service provisions that are necessary for precision in treatment and improved patient outcomes. Knowledge generated from the network is disseminated via physician education activities organized by the Asian Pacific Society of Primary Immunodeficiencies (APSID), which we founded in 2016. Our stakeholder engagement activities raise PID awareness and policy support for our patients. HKU’s leadership in PID is recognized internationally.
Dr Lee is the Chair of the Genetics and Genomics Working Party of APSID, and a member of the Executive Board. She has played a key role in the design and implementation of the APSID Schools Designed for young doctors in training, the APSID Schools adopt intensive learner engagement through self-directed learning, active participation and feedback. Up to the end of 2018, 7 APSID Schools have been conducted with 312 presentations given by trainees from 15 Asian countries and regions. She is a member of the Organizing Committee of the First International Alliance of Primary Immunodeficiency Societies (IAPIDS) Advanced Summer School 2020.
Viva-Asia Blood and Marrow Transplant (VABMT) Consortium
Dr Lee is currently the Vice Chair of the VABMT Consortium. She set up the VABMT Education Initiative in 2017 when she took up the role as the Chair of the Education Subcommittee. The mission is to bring together international and regional experts to educate physicians on the best practice and standard of care in pediatric HSCT. Recognizing the diversity of needs and priorities of HSCT-related issues in various Asian countries, the Consortium strives to enable knowledge exchange (KE) activities from basic to highly specialized, cutting edge HSCT approach and cellular therapy, through an education platform that facilitates collaborative learning. We believe that, by efforts in education and training, every patient undergoing HSCT can benefit from the prevailing best clinical practice, based on safe, evidence-based, effective and innovative medicine. We aim to empower emerging programs to set up and expand their HSCT service with support from centers of excellence, and at the same time, to drive innovations and nurture the next generation of leaders in pediatric HSCT. Our vision is that HSCT will be accessible to each and every child who requires this life-saving procedure and be cured of his / her disease to live a life to its full potential, regardless of nationality and residence.
|- Best Young Investigator Prize||Hong Kong College of Paediatricians, 2018|
|- Best Research Award||11th Congress of Asian Society for Pediatric Research, 15-18/4/2015, Japan|
|- Young Investigator Award||6th Congress of Asian Society for Pediatric Research, 15-18/4/2008, Taiwan.|
|- Young Investigator Award||Pediatric Academic Societies and Asian Society for Pediatric Research 2008 Joint Meeting, May 3-6 2008, USA|
|- Young Investigator Award||2nd Congress of Asian Society for Pediatric Research, Dec 2006, Japan.|
|- Best Paper Award||2019 World Federation for Medical Education (WFME) World Conference|
|- Award of Merit||Frontiers in Medical and Health Sciences Education 2018|
|- Audience Award||Frontiers in Medical and Health Sciences Education 2018|
|- First Runner-up||7th Asia Pacific Medical Education Conference (APMEC), Singapore, 2010.|
|- Faculty Teaching Medal||LKS Faculty of Medicine, 2009.|